Simplex Trading
SMMT icon

Simplex Trading’s Summit Therapeutics SMMT Stock Holding History

Simplex Trading’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
77,300
+50,300
+186% +$892K ﹤0.01% 2657
2026
Q1 		$512K Sell
27,000
-117,700
-81% -$1.9M ﹤0.01% 3238
2025
Q4 		$2.53M Sell
144,700
-75,600
-34% -$1.42M ﹤0.01% 1789
2025
Q3 		$4.55M Sell
220,300
-131,800
-37% -$3.2M ﹤0.01% 1552
2025
Q2 		$7.49M Buy
352,100
+96,600
+38% +$2.2M ﹤0.01% 1070
2025
Q1 		$4.93M Buy
255,500
+36,700
+17% +$736K ﹤0.01% 1314
2024
Q4 		$3.9M Buy
218,800
+84,600
+63% +$1.64M ﹤0.01% 1656
2024
Q3 		$2.94M Buy
134,200
+9,900
+8% +$138K ﹤0.01% 1944
2024
Q2 		$969K Buy
124,300
+100,200
+416% +$541K ﹤0.01% 2946
2024
Q1 		$99K Sell
24,100
-13,100
-35% -$52.1K ﹤0.01% 5589
2023
Q4 		$97K Sell
37,200
-22,800
-38% -$46.9K ﹤0.01% 5425
2023
Q3 		$112K Buy
60,000
+52,800
+733% +$101K ﹤0.01% 4981
2023
Q2 		$18K Sell
7,200
-15,900
-69% -$29K ﹤0.01% 6896
2023
Q1 		$40K Sell
23,100
-24,900
-52% -$67.9K ﹤0.01% 6180
2022
Q4 		$204K Buy
48,000
+26,400
+122% +$48K ﹤0.01% 4205
2022
Q3 		$25K Buy
+21,600
New +$24.4K ﹤0.01% 7289
2022
Q1 		– Sell
-800
Closed -$2K – 11321
2021
Q4 		$2K Sell
800
-1,800
-69% -$8.65K ﹤0.01% 10053
2021
Q3 		$20K Hold
2,600
– – ﹤0.01% 8452
2021
Q2 		$19K Buy
2,600
+2,593
+37,043% +$17K ﹤0.01% 8638
2021
Q1 		$4K Buy
+7
New +$45 ﹤0.01% 8296

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Simplex Trading's SMMT Position: Q2 2026 in Review

Simplex Trading reduced its Summit Therapeutics (SMMT) stake by 77% in Q2 2026, selling an estimated $114K and leaving 1,968 shares worth $28.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6797.

Simplex Trading first reported a position in SMMT in Q2 2018 and has held it in 12 quarters since. The position peaked at $894K in Q2 2024. 243 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Simplex Trading held 1,968 shares of Summit Therapeutics worth $28.7K as of Q2 2026.
  • Simplex Trading sold 6,442 Summit Therapeutics shares in Q2 2026, an estimated $114K.
  • Summit Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6797 holding.
  • Simplex Trading first reported a position in Summit Therapeutics in Q2 2018 and has held it in 12 quarters since.
  • Simplex Trading's Summit Therapeutics position peaked at $894K in Q2 2024.
  • 243 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.